vimarsana.com
Home
Live Updates
Johnson & Johnson Reports Q4 and Full-Year 2021 Results : vi
Johnson & Johnson Reports Q4 and Full-Year 2021 Results : vi
Johnson & Johnson Reports Q4 and Full-Year 2021 Results
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced results for fourth-quarter and full year 2021. "Our 2021 performance reflects continued strength...
Related Keywords
South Africa ,
United States ,
Canada ,
Johnson ,
Consumer Health Business ,
Digital Surgery Solutions ,
European Commission Approves ,
Microsoft ,
Paliperidone Palmitate ,
Maintenance Treatment ,
Multiple Myeloma After First ,
Conditional Marketing Authorisation ,
First Treatment Approved ,
Advanced Nonsmall Cell Lung Cancer ,
Mutations After Failure ,
Booster Shot Authorized ,
Emergency Use ,
Health Organization Strategic Advisory Group ,
Interim Recommendation Supports Use ,
Booster Shot ,
Two New Indications ,
Help Prevent ,
Treat Blood Clots ,
Seeks Approval ,
Fixed Duration Regimen ,
Untreated Chronic Lymphocytic Leukaemia ,
Submits Biologics License Application ,
Refractory Multiple ,
Johnson Announces Plans ,
Accelerate Innovation ,
Serve Patients ,
Unlock Value ,
Separate Consumer Health ,
Johnson Appoints Senior Leaders ,
Further Enable ,
Digital Surgery ,
Administered Six Months After Two Dose Regimen ,
Shows Substantial Increase ,
Johnson Enters ,
Most Vulnerable People ,
Novel Humanitarian ,
Johnson Amp ,